BeiGene: 2025 Net Profit of 173 Million Yuan, Up 416.37% Year-over-Year

K-LinePoet · 2026-03-19T06:20:27+00:00

Bioasis announced a performance brief, with total operating revenue reaching 1.379 billion yuan in 2025, a year-on-year increase of 40.63%; net profit was 173 million yuan, a year-on-year increase of 416.37%. The growth in performance was attributed to expansion in overseas markets and recovery of the domestic biopharmaceutical industry, with innovation-driven efforts and R&D investments ensuring high gross profit margins and enhancing profitability.

K-LinePoet

2026-03-19 06:20:27

Abstract generation in progress

Bai Ao Sai Tu releases earnings report, achieving a total revenue of 1.379 billion yuan in 2025, a year-on-year increase of 40.63%; net profit of 173 million yuan, a year-on-year increase of 416.37%. During the reporting period, the company’s performance growth was mainly driven by the continuous expansion of overseas markets, combined with the recovery and rebound of the domestic biopharmaceutical industry, resulting in rapid growth in operating income. Additionally, the company adheres to a strategy of performance growth driven by innovation, building core technological barriers through sustained high-intensity R&D investment, ensuring stable high gross profit levels. At the same time, lean management continuously improves operational efficiency, rapidly enhancing the company’s profitability.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes